https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/accumulated-depreciation https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/amended-reports-10-k https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/amended-reports-10-k405 https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/amortization-of-financing-costs https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/aoci https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/assets-fair-value-disclosure https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/available-for-sale-securities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/basic-shares https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/buybacks-form-sc-to-i https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/buybacks-share-repurchases https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/capital-expenditures https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/capital-lease-obligations-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/cash-acquired-from-acquisition https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/cash-and-equivalents https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/cash-flow-breakdown https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/clinical-trials https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/common-stock-value https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/comprehensive-income https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/convertible-long-term-notes-payable https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/convertible-notes-payable-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/cover-page-shares-outstanding https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/current-assets https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/current-liabilities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-convertible-conversion-price https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-convertible-interest-expense https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-face-amount https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-increase-additional-borrowings https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-compensation-share-based-arrangements-liability-classified-noncurrent https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-compensation-share-based-arrangements-liability-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-costs https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-revenue https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-revenue-2 https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-revenue-and-credits https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-revenue-noncurrent https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-revenue-refund-payments https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-tax-assets-gross https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-tax-assets-other https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deposits-assets-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/deposits-assets-noncurrent https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/depreciation-and-amortization https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/diluted-shares https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/due-to-related-parties-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/eps https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/eps-basic https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/financing-cash-flow https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/form-d-stocks https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/general-and-administrative-expense https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/increase-in-carrying-amount-of-redeemable-preferred-stock https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/insider-transactions-corporate-securities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/insider-transactions-preferred https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/insider-transactions-stock-options https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/interest-expense https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/interest-income-expense-net https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/interest-paid https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/interest-payable-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/investing-cash-flow https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/investment-income-interest-and-dividend https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/lease-and-rental-expense https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/long-term-notes-payable https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/marketable-securities-restricted-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/marketable-securities-unrealized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/net-change-in-cash https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/net-income https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/notes-and-loans-payable-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/notes-payable-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/oci-available-for-sale-adjustment-before-reclassification-adjustments-net-of-tax https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/oci-securities-sale-reclassification-net-of-tax https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/oci-tax https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/operating-cash-flow https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/operating-expenses https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/operating-income https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/other-commitment-due-in-next-twelve-months https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/other-commitment-due-in-second-year https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/other-current-liabilities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/other-noncurrent-liabilities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/other-nonoperating-income-expense https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/other-preferred-stock-dividends-and-adjustments https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/paid-in-capital-increase-in-carrying-amount-of-redeemable-preferred-stock https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/payments-for-repurchase-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/payments-of-dividends-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/payments-of-financing-costs https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/preferred-shares-facts https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/preferred-stock-conversions-inducements https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/preferred-stock-shares-authorized https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/preferred-stock-shares-issued https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/preferred-stock-value https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-convertible-debt https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-license-fees-received https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-related-party-debt https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-sale-of-available-for-sale-equity https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/proceeds-from-stock-issued https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/property-plant-and-equipment-gross https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/property-plant-equipment https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/public-float https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/realized-gains-on-securities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/repayments-of-notes-payable https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/research-and-development-in-process https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/retained-earnings https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/retained-earnings-appropriated https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/revenue https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sale-of-stock-price-per-share https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-comment-letters-corresp https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-comment-letters-upload https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-10-c https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-10-k https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-10-k405 https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-10-q https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-15-12g https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-25-nse https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-8-a12g https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-8-k https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-ars https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-ct-order https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-def-14a https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-defa14a https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-defr14a https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-pre-14a https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-prer14a https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/sec-filings-regdex https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/secondary-offerings-form-effect https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/shareholders-equity https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/shares-authorized https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/shares-issued https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/shares-issued-for-options-exercised https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/shares-issued-value-other https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/short-term-investments https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-based-compensation https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-issued-new-shares-sold https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-exercisable-number https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-grants-in-period https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/stock-options-outstanding-number https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/tax-rate-reconciliation-tax-settlements https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/temporary-equity-shares-authorized https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/temporary-equity-shares-issued https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/temporary-equity-value-excluding-additional-paid-in-capital https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/total-assets https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/total-liabilities https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/total-liabilities-and-equity https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/unrecognized-tax-benefits https://stock.noler.com/us/stock/alseres-pharmaceuticals-inc-de/weighted-average-number-of-share-outstanding-basic-and-diluted